Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Interest Expenses (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Interest Expenses for 6 consecutive years, with $894000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 7.74% to $894000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.6 million, a 14.29% decrease, with the full-year FY2025 number at $3.6 million, down 14.29% from a year prior.
  • Interest Expenses was $894000.0 for Q4 2025 at PROCEPT BioRobotics, down from $919000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.5 million in Q3 2021 to a low of $866000.0 in Q4 2022.
  • A 5-year average of $1.1 million and a median of $1.0 million in 2024 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: crashed 39.86% in 2022, then grew 29.91% in 2023.
  • PROCEPT BioRobotics' Interest Expenses stood at $1.4 million in 2021, then plummeted by 39.86% to $866000.0 in 2022, then increased by 29.91% to $1.1 million in 2023, then fell by 13.87% to $969000.0 in 2024, then decreased by 7.74% to $894000.0 in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Interest Expenses are $894000.0 (Q4 2025), $919000.0 (Q3 2025), and $896000.0 (Q2 2025).